Results 71 to 80 of about 100,610 (328)

Safety and Efficacy of 10 kHz Spinal Cord Stimulation for the Treatment of Refractory Chronic Migraine: A Prospective Long‐Term Open‐Label Study

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Background Refractory chronic migraine (rCM) is a highly disabling condition for which novel safe and effective treatments are needed. Safety and long‐term efficacy of paresthesia‐free high cervical 10 kHz spinal cord stimulation (SCS) were here prospectively evaluated for the treatment of rCM.
Adnan Al‐Kaisy   +7 more
wiley   +1 more source

Treatment of masseteric hypertrophy with botulinum toxin : a report of two cases [PDF]

open access: yes, 2010
Masseter muscle hypertrophy is a rare condition of unknown cause which is important in the differential diagnosis of head and neck masses, located in the cheek.
Bas, Burcu   +3 more
core   +1 more source

Botulinum toxin and spasticity [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2000
The clinical effects of botulinum toxin have been recognised since the end of the 19th century. It is the most potent neurotoxin known and it is produced by the gram negative anaerobic bacterium Clostridium botulinum. The paralytic effect of the toxin is due to blockade of neuromuscular transmission.1 Injection into a muscle causes chemodenervation and
Michael P Barnes, Elizabeth C. Davis
openaire   +2 more sources

Postoperative Fluoroscopic Appearance After Flexible Endoscopic Zenker's Diverticulotomy

open access: yesThe Laryngoscope, EarlyView.
We perform a retrospective study on patients undergoing flexible Zenker's diverticulotomy surgery and report changes in the objective fluoroscopic appearance as well as patient‐reported outcome measures. ABSTRACT Objective Flexible approach to treating Zenker's diverticulum (ZD) has gained traction in recent years. However, objective measures comparing
Shumon I. Dhar   +7 more
wiley   +1 more source

Botulinum toxin injections as a method for chemically denervating skeletal muscle to test functional hypotheses: a pilot study in Lepomis cyanellus [PDF]

open access: yes, 2007
In this study, we demonstrate that botulinum toxin can be used to chemically denervate muscles to test functional hypotheses. We injected research-grade type A botulinum toxin complex into pectoral fin abductors (abductor superficialis) of green sunfish (
Gibb, Alice C., O'Neill, Matthew W.
core   +1 more source

The use of botulinum toxin in keloid scar management: a literature review

open access: yesScars, Burns & Healing, 2020
Introduction: Administration of botulinum toxin is an increasingly popular procedure in the medical and aesthetic field. There is emerging evidence that it can influence fibroblast activity and minimise tension around the scar by virtue of muscular ...
Catrin Sohrabi, Ioannis Goutos
doaj   +1 more source

Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H. [PDF]

open access: yes, 2016
BackgroundOnly Clostridium botulinum strain IBCA10-7060 produces the recently described novel botulinum neurotoxin type H (BoNT/H). BoNT/H (N-terminal two-thirds most homologous to BoNT/F and C-terminal one-third most homologous to BoNT/A) requires ...
Arnon, Stephen S   +5 more
core   +1 more source

A Randomized, Double‐Blind, Placebo Controlled, Crossover Trial of incobotulinumtoxinA Treatment for Upper Limb Tremor

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Proximal upper limb tremor is a common, functionally disabling condition. Medical therapy is often ineffective. IncobotulinumtoxinA can significantly improve tremor with minimal adverse effects. Objectives We aimed to compare clinical, functional, and quality of life measures in patients with proximal upper limb tremor following ...
Sai A. Nagaratnam   +10 more
wiley   +1 more source

Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity

open access: yesActa Médica Portuguesa, 2020
Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin ...
Alexandre Camões- Barbosa   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy